Cargando…

Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells

BACKGROUND: Suberoyl bis-hydroxamic acid (SBHA) is a histone deacetylase (HDAC) inhibitor and exerts anti-growth effects in several malignancies including breast cancer. Proteasome inhibitors such as Bortezomib and MG-132 constitute novel anticancer agents. In this study, we investigated the synergi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xinmiao, Shi, Zeliang, Zhang, Ning, Ou, Zhouluo, Fu, Shen, Hu, Xichun, Shen, Zhenzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342900/ https://www.ncbi.nlm.nih.gov/pubmed/25729327 http://dx.doi.org/10.1186/s12935-014-0107-7

Ejemplares similares

Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens
por: Bakri, Ridla, et al.
Publicado: (2014)

Enhancement of the Controlled-Release Properties of Chitosan Membranes by Crosslinking with Suberoyl Chloride
por: Chen, Chao, et al.
Publicado: (2013)

Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth
por: Said, Thenaa K, et al.
Publicado: (2001)

Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms
por: Liu, Zhaohui, et al.
Publicado: (2014)

Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
por: Wen, Shao-hsuan, et al.
Publicado: (2018)

Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors
por: Orabi, Khaled Y, et al.
Publicado: (2013)

Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer
por: Mezil, Lynda, et al.
Publicado: (2012)

Suppression of TCAB1 expression induced cellular senescence by lessening proteasomal degradation of p21 in cancer cells
por: Niu, Jing, et al.
Publicado: (2021)

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration †
por: Yu, Xueliang, et al.
Publicado: (2021)

Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
por: St Germain, Carly, et al.
Publicado: (2010)

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
por: Aveic, Sanja, et al.
Publicado: (2018)

Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
por: Ortiz-Lazareno, Pablo César, et al.
Publicado: (2014)

Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells
por: Li, Pengying, et al.
Publicado: (2016)

Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis
por: Liu, Yangyang, et al.
Publicado: (2022)

Proteasome-mediated degradation antagonizes critical levels of the apoptosis-inducing C1D protein
por: Rothbarth, Karsten, et al.
Publicado: (2002)

Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
por: Flis, Sylwia, et al.
Publicado: (2009)

Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
por: Leipoldt, Franziska, et al.
Publicado: (2017)

A novel autophagy-related genes prognostic risk model and validation of autophagy-related oncogene VPS35 in breast cancer
por: Li, Xiaoying, et al.
Publicado: (2021)

Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
por: Shi, Yonghua, et al.
Publicado: (2016)

Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC
por: Huang, Yiwen, et al.
Publicado: (2021)

Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation
por: Xiao, Zhiyuan, et al.
Publicado: (2020)

Snapshots of Dynamic Adaptation: Two‐Dimensional Molecular Architectonics with Linear Bis‐Hydroxamic Acid Modules
por: Jing, Chao, et al.
Publicado: (2019)

Short-term starvation synergistically enhances cytotoxicity of Niraparib via Akt/mTOR signaling pathway in ovarian cancer therapy
por: Zhi, Wang, et al.
Publicado: (2022)

Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
por: Osman, Abdel-Moneim M, et al.
Publicado: (2012)

Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2012)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

Molecular docking and ADMET analysis of hydroxamic acids as HDAC2 inhibitors
por: Alsawalha, Murad, et al.
Publicado: (2019)

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
por: Zhao, Na, et al.
Publicado: (2020)

Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor
por: Linnert, Miriam, et al.
Publicado: (2021)

Interaction of Imidazole Containing Hydroxamic Acids with Fe(III): Hydroxamate Versus Imidazole Coordination of the Ligands
por: Farkas, Etelka, et al.
Publicado: (2007)

Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
por: Chiu, Hui-Wen, et al.
Publicado: (2013)

Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells
por: Patrikidou, Anna, et al.
Publicado: (2011)

Genome-wide identification of genetic determinants for the cytotoxicity of perifosine
por: Zhang, Wei, et al.
Publicado: (2008)

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP(s)
por: Francois, Rony A., et al.
Publicado: (2019)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line
por: Visagie, Michelle H, et al.
Publicado: (2012)

Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors
por: Liu, Chuan, et al.
Publicado: (2012)

Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells
por: Verwey, Marcel, et al.
Publicado: (2016)

Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
por: Oh, Se-Jeong, et al.
Publicado: (2017)

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression
por: Chlapek, Petr, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4sep1j33fcmpaeabu6qc0o456d